Sector portfolio · VC firm · Japan

Mitsubishi UFJ Capital's Biotech portfolio

Mitsubishi UFJ Capital has backed 19 Biotech startups in rounds we track, $390M between them, shown by the stage each has reached. The best-funded is Cardiac Dimensions.

19startups backed
3stages
$390Mraised between them
Series Bbiggest stage

Mitsubishi UFJ Capital's whole portfolioMitsubishi UFJ Capital's profile

Series B

8

Stage not reported

7

Series A

4

Segment by segment

Series B

8 startups · $260M raised

  1. Cardiac DimensionsCardiac Dimensions is a medical device company based in Kirkland, Washington, founded in 2001.United States$150M
  2. Neusignal TherapeuticsNeusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.Japan$40M
  3. CTCohesive TechnologiesCohesive Technologies Inc.United States$23M
  4. Rege NephroRege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.Japan$15M
  5. iHeartiHeart is a health technology company founded by medical experts, including Dr.United States$15M
  6. MIModulated ImagingUnited States$9.9M
  7. CellAxiaCellAxia is a biotechnology startup that creates medications for cell treatment.Japan$6.6M
  8. RadioNano TherapeuticsRadioNano Therapeutics is a medical technology company that develops radiation therapy solutions for the treatment of cancer patients.Japan$955K

Stage not reported

7 startups · $48M raised

  1. LogomixLogomix is a Japanese synthetic biology and genome engineering company founded in 2019 and based in Tokyo.Japan$19M
  2. JOJapanese Organization for Medical Device DevelopmentJapanese Organization for Medical Device Development is a research and development company of medical equipment.Japan$9.2M
  3. CellspectCellspect is a development of clinical diagnostic methods by sensing disease markers.Japan$6.9M
  4. GlyTechGlyTech is a responsibility of the company to protect personal information in its business activities.Japan$4.6M
  5. StapleBioStapleBio is a bio-tech company that focuses on the research and development of pharmaceuticals based on staple nucleic acid technology.Japan$3.0M
  6. Epsilon Molecular EngineeringEpsilon Molecular Engineering is a Biotechnology research and development company.Japan$2.7M
  7. Lily MedTechLily MedTech is conducting research on imaging systems for breast cancer.Japan$2.3M

Series A

4 startups · $83M raised

  1. Shinobi TherapeuticsShinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment.United States$68M
  2. FELIQSFELIQS is a research-based start-up specializing in pharmaceutical sciences.Japan$8.3M
  3. TNAX BiopharmaTNAX Biopharma is a biopharmaceutical company that offers the development and commercialization of novel antibody therapeutics drugs.United States$4.6M
  4. Kamui PharmaKamui Pharma, Inc.Japan$2.0M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Mitsubishi UFJ Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioMitsubishi UFJ Capital's AI portfolio34 startups · $845MSector portfolioMitsubishi UFJ Capital's Healthtech portfolio15 startups · $189MPortfolio mapMitsubishi UFJ Capital portfolio map140 startups · $5.2BCo-investorsWho invests with Mitsubishi UFJ Capital97 co-investorsInvestments abroadMitsubishi UFJ Capital's investments in the United States17 startups · $3.5BSector portfolioGlobal Brain Corporation's AI portfolio39 startups · $1.4B

Raising from investors like Mitsubishi UFJ Capital?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps